colostrom and glutathione catalase Antioxidant Activity of Bovine Colostrum in the Colon of a Mouse Model of TNBS-Induced Colitis Effect of hydrolysis degree with

Disclosures: Marie-Agns M'CALLUM: Nothing to Disclose, Quang Toan PHAM: Nothing to Disclose, Kristen Vieira-Lomasney: Nothing to Disclose, Eytan Haddad: Nothing to Disclose, Silvia Selleri: Abcellera Biologics: Employee, Massimiliano Paganelli: Morphocell Technologies: Executive role 1162 ASSOCIATION OF GLUCAGON-LIKE PEPTIDASE 1 RECEPTOR AGONIST WITH LIVER AND NON-LIVER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Mindie Nguyen 1 Xianhua Mao 1 Xinrong Zhang 1 Rongtao Lai 2 Ka-Shing Cheung 3 Man-Fung Yuen 3 Ramsey Cheung 1 Wai-Kay Seto 3 , 1 Stanford University Medical Center, 2 Shanghai Jiao Tong University School of Medicine, 3 The University of Hong Kong Background: Although individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease (diabetic MASLD) face a higher lifelong risk of developing liver and non-liver morbidities, there so far are limited effective pharmacological strategies to reduce the disease burden in this population

Results and treatment time may vary.Medication may be provided, only after a consultation by a medical provider.

If blood appears, reposition

PMID: 255 KhanCKiranKPrasadMGuraoR